Recently, it was reported that downregulation of KMO activity significantly inhibited cell proliferation of tumor cells and KMO may be a potential biomarker for tumor diagnosis (Chiu, Lei, Huang, Chiang, & Lin, 2019). The gene discussed is KMO; the disease is neoplasm.